Review

A contribution to the study of crystalluria: significance in the diagnosis of metabolic and renal diseases

Volume: 5 Number: 2 August 31, 2020
  • Muhamed Katica *
  • Nasreldin Hassan Ahmed
  • Nedžad Gradaščević
  • Alen Salkić
  • Emina Dervišević
EN

A contribution to the study of crystalluria: significance in the diagnosis of metabolic and renal diseases

Abstract

The study of crystalluria is of great importance for the detection of substances of endogenous or exogenous origin that are present inthe urine, to a greater or lesser extent. Urinary sediment crystals can provide valuable answers for the assessment of therapeutic efficacy, as well as congenital and/or acquired pathophysiological conditions. The nature of the observed crystals informs the clinician of the biochemical irregularity of the urine. Crystalluria is of clinical significance only if it has been studied under good test conditions (sample selection, time and storage conditions). Crystalluria interpretations are performed on the basis of the urinary pH determined with statistically significant reliability. When studying crystalluria by light microscopy, it is necessary to provide light polarization or bidirectional illuminationin order to reduce the risk of diagnostic error.

Keywords

References

  1. Abraham, P.A., Smith, C.L. (1987). Evaluation of factors involved in calcium stone formation. Miner Electrolyte Metab 13, 201–8.
  2. Azoury, R., Robertson, W.G., Garside, J. (1987). Observations on in vitro and in vivo calcium oxalate crystalluria in primary calcium stone formers and normal subjects. Br J Urol 59(3), 211-213.
  3. Bader, C.A., Chevalier, A., Hennequin, C., Jungers, P., Daudon, M. (1994). Methodological aspects of spontaneous crystalluria studies in calcium stone formers. Scanning Microsc 8, 215–32.
  4. Bush, B.M. (1998). Interpretation of Laboratory Results for Small Animal Clinicians. 5th Ed., Cornwall: MPG Books Ltd, Bodmin.
  5. Cairo, M.S., Bishop, M. (2004). Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127, 3–11.
  6. Daudon, M., Frochot, V. (2015). Crystalluria. De Grutyer-Clin Chem Lab Med. 53(Suppl), S1479–S1487. DOI 10.1515/cclm-2015-0860
  7. Daudon, M., Hennequin, C., Bader, C., Jungers, P., Lacour, B., Drueke, T. (1995). Inhibitors of crystallization. Adv Nephrol 24,167–216.
  8. Daudon, M., Jungers, P., Lacour, B. (2004). Intéręt clinique de l’étude de la cristallurie. Ann Biol Cli 62, 379–93.

Details

Primary Language

English

Subjects

Veterinary Sciences

Journal Section

Review

Authors

Nasreldin Hassan Ahmed This is me
0000-0002-5728-7052
Türkiye

Nedžad Gradaščević This is me
0000-0003-4759-3192
Bosnia and Herzegovina

Alen Salkić This is me
0000-0002-5728-7052
Bosnia and Herzegovina

Emina Dervišević This is me
0000-0002-5728-7052
Bosnia and Herzegovina

Publication Date

August 31, 2020

Submission Date

May 10, 2020

Acceptance Date

August 28, 2020

Published in Issue

Year 2020 Volume: 5 Number: 2

APA
Katica, M., Hassan Ahmed, N., Gradaščević, N., Salkić, A., & Dervišević, E. (2020). A contribution to the study of crystalluria: significance in the diagnosis of metabolic and renal diseases. Journal of Advances in VetBio Science and Techniques, 5(2), 81-89. https://doi.org/10.31797/vetbio.735104

Cited By

22563     logo_world_of_journals_no_margin.png     logo.png        google-scholar.jpg?itok=fFLzEt0n